Friday, September 24, 2021 2:25:00 PM
Fact 1. NWBO sold Sawston to keep funding the trial that will make you rich. They retained 17 acres that most likely will be worth a lot of money in development.
Fact 2. So what?
Fact 3. Big deal.
Fact 4. Who cares?
Fact 5. NWBO gets paid for vaccines. NWBO pays Advent to use NWBO’s equipment to make the vaccine. What part of this is so foreign to you?
Fact 6. If Advent is sold they’re selling their people’s skills, their only asset. Are you asserting Advent could simply go create their own plant and make DCVax without NWBO? NWBO could hire another company of people with the same skills. Contract manufacturing is a part of Pharma and become the norm, not the exception. A CRO, CMO, or CTL is standard stuff and you and others keep trying to make it out to be something unusual or bad for shareholders. I have experience in this, and you’re misguided at best
Fact 2. So what?
Fact 3. Big deal.
Fact 4. Who cares?
Fact 5. NWBO gets paid for vaccines. NWBO pays Advent to use NWBO’s equipment to make the vaccine. What part of this is so foreign to you?
Fact 6. If Advent is sold they’re selling their people’s skills, their only asset. Are you asserting Advent could simply go create their own plant and make DCVax without NWBO? NWBO could hire another company of people with the same skills. Contract manufacturing is a part of Pharma and become the norm, not the exception. A CRO, CMO, or CTL is standard stuff and you and others keep trying to make it out to be something unusual or bad for shareholders. I have experience in this, and you’re misguided at best
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
